Summary
ABL has an exceptional history in the development and production of preclinical and clinical virus-based biologics.  From 30 years of groundbreaking work with HIV to supporting the latest gene therapy technologies, ABL offers a comprehensive portfolio of services for the effective design, development, production and testing of vaccine and gene therapy candidates.

Services
Virus seed stock development
Plaque purification
cGMP virus banking
Method development & qualification
Plaque assay
TCID50
MOI
Cell-based assays
ELISA
Immunoassay
Viral lysate production
Upstream process development
Downstream purification development
Production of toxicology supply
cGMP production of clinical supply
Aseptic fill/finish of final drug product

Capabilities
Bioreactor
Roller Bottles
Cell Factories
Flasks
Column Chromatography
Sucrose Gradient Cushion
Cesium Chloride Gradient
TFF
Continuous Centrifugation

Experience
Adenovirus
MVA
Lentivirus
Other retroviruses
Lytic and non-lytic viruses
Enveloped and non-enveloped viruses

Project Management

Quality Assurance